News 29.01.2026 Schlieren, Zurich – DiNAMIQS has appointed Kathrin Schneider as its new Head of Business Development for Europe and the Asia-Pacific region (APAC). According to the Schlieren-based life sciences company, she has experience in establishing structures that enable sustainable, long-term growth. DiNAMIQS, based in the Bio-Technopark Schlieren-Zurich, has expanded its management team...
News 19.01.2026 We are pleased to announce that our acquisition of Doppl SA, including the Sun Bioscience technology, has officially been completed. This milestone expands our capabilities in human-relevant 3D biology and strengthens the support we offer across preclinical research. Doppl brings a distinctive organoid technology portfolio featuring tessellated organoid arrays, a leading biobank,...
News 15.01.2026 Unlike typical award programs, this recognition is based entirely on platform performance metrics, reflecting real activity and real outcomes across global R&D teams. Over the past year, scientists requested and completed studies spanning: 🔹 in vitro toxicology 🔹 pharmacology and assay development 🔹 cell culture and characterization All delivered through an on-demand procurement workflow. Performance indicators...
News 14.01.2026 Zurich, Switzerland - 13.01.2026 Neurimmune today announced that the company joined the ACCESS-AD consortium, a new European initiative to accelerate the implementation of scientific innovations for Alzheimer’s disease (AD) management in real-world health systems. The international consortium - bringing together academic institutions, industry partners, SMEs and patient organisations - is a five-year...
News 13.01.2026 Schlieren (Zürich), Switzerland, January 13, 2026 – Kuros Biosciences (“Kuros” or the “Company”) a leader in innovative biologic technologies, today announced a series of milestones including key IDN (Integrated Delivery Network) health system approvals, significant regulatory approval, and published preclinical evidence supporting the continued adoption and global expansion of MagnetOs™,...